{"recordsFiltered":49251,"recordsTotal":49251,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-status&start=34500","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-status&start=33900","results":[{"registry_id":"NCT06100874","publication_url":"https://clinicaltrials.gov/study/NCT06100874","title":"A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)","has_exemption":false,"start_date":"2023-11-20","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Adrienne G. Waks","sponsor_slug":"adrienne-g-waks","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06367387","publication_url":"https://clinicaltrials.gov/study/NCT06367387","title":"Pain Self-Management and Patient-Oriented Dosing for Pain and Retention in Office-based Addiction Treatment: a Randomized Trial","has_exemption":false,"start_date":"2024-05-28","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Erin Winstanley","sponsor_slug":"erin-winstanley","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06046443","publication_url":"https://clinicaltrials.gov/study/NCT06046443","title":"A Randomized, Placebo-controlled, Double-Blind Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity, With an Open-Label Extension","has_exemption":false,"start_date":"2024-07-11","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06531538","publication_url":"https://clinicaltrials.gov/study/NCT06531538","title":"A PHASE 2, RANDOMIZED, PARTIALLY DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE ADMINISTERED IN HEALTHY TODDLERS 12 THROUGH 15 MONTHS OF AGE","has_exemption":false,"start_date":"2024-07-30","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06737042","publication_url":"https://clinicaltrials.gov/study/NCT06737042","title":"EFFICACY and SAFETY of GZR18 INJECTED EVERY 2 WEEKS (Q2W) in PARTICIPANTS WITHOUT TYPE 2 DIABETES, WHO HAVE OBESITY or ARE OVERWEIGHT: a RANDOMIZED, TIRZEPATIDE- and PLACEBO-CONTROLLED STUDY","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Gan and Lee Pharmaceuticals, USA","sponsor_slug":"gan-and-lee-pharmaceuticals-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07445958","publication_url":"https://clinicaltrials.gov/study/NCT07445958","title":"In-Clinic Assessment of Vaginal Mucosal Safety Following Repetitive Use of the Livi Device","has_exemption":false,"start_date":"2026-01-28","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Atlantic Health System","sponsor_slug":"atlantic-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01247207","publication_url":"https://clinicaltrials.gov/study/NCT01247207","title":"An Open-Label, Safety Study for Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy","has_exemption":false,"start_date":"2010-11-30","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"PTC Therapeutics","sponsor_slug":"ptc-therapeutics","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01543659","publication_url":"https://clinicaltrials.gov/study/NCT01543659","title":"A Phase I/II Study of Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer","has_exemption":false,"start_date":"2012-02-21","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05588843","publication_url":"https://clinicaltrials.gov/study/NCT05588843","title":"A Randomized, Double-blind, Placebo Controlled, Dose-finding Study to Assess the Efficacy and Safety of SAR443122 in Adult Patients With Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2022-11-25","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05639543","publication_url":"https://clinicaltrials.gov/study/NCT05639543","title":"A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Escalation, Proof-of-Concept Study Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetics of INT-787 in Subjects With Severe Alcohol Associated Hepatitis","has_exemption":false,"start_date":"2022-12-15","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Intercept Pharmaceuticals","sponsor_slug":"intercept-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05776004","publication_url":"https://clinicaltrials.gov/study/NCT05776004","title":"A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of CAL02 Administered Intravenously in Addition to Standard of Care in Subjects With Severe Community-Acquired Bacterial Pneumonia (SCABP)","has_exemption":false,"start_date":"2023-07-22","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Eagle Pharmaceuticals, Inc.","sponsor_slug":"eagle-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05798520","publication_url":"https://clinicaltrials.gov/study/NCT05798520","title":"A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multiple Sclerosis","has_exemption":false,"start_date":"2023-07-25","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06173791","publication_url":"https://clinicaltrials.gov/study/NCT06173791","title":"Demineralized Bone Allograft Fibers Versus Particulate In Sinus Augmentation: A Double Arm Randomized Control And Histomorphometric Study","has_exemption":false,"start_date":"2023-09-25","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299826","publication_url":"https://clinicaltrials.gov/study/NCT06299826","title":"A Phase IIb Two-Cohort, Randomised, Placebo-controlled, Double-blind, Multi-centre, Dose-ranging Study of AZD5462 in Stable Patients With Chronic Heart Failure","has_exemption":false,"start_date":"2024-06-04","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06352372","publication_url":"https://clinicaltrials.gov/study/NCT06352372","title":"Safety and Efficacy of Transcranial Photobiomodulation (tPBM) for Individuals With Autism Spectrum Disorder and Epileptiform Activity","has_exemption":true,"start_date":"2024-07-01","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Richard Frye","sponsor_slug":"richard-frye","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06634420","publication_url":"https://clinicaltrials.gov/study/NCT06634420","title":"HAELO: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2002 in Participants With Hereditary Angioedema (HAE)","has_exemption":false,"start_date":"2025-01-15","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Intellia Therapeutics","sponsor_slug":"intellia-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06618976","publication_url":"https://clinicaltrials.gov/study/NCT06618976","title":"SOTA-THROMBOSIS: Antithrombotic Activities of Sotagliflozin vs. Empagliflozin","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06787690","publication_url":"https://clinicaltrials.gov/study/NCT06787690","title":"A Prospective Multicenter Single-arm Clinical Study to Investigate Clinical Outcomes When Cohealyx™ is Used for the Management of Full Thickness Wounds Post-surgical Excision","has_exemption":false,"start_date":"2025-05-15","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Avita Medical","sponsor_slug":"avita-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04875364","publication_url":"https://clinicaltrials.gov/study/NCT04875364","title":"Do Endotypes Predict Response and Sequelae in OSA Patients","has_exemption":false,"start_date":"2020-08-01","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05155605","publication_url":"https://clinicaltrials.gov/study/NCT05155605","title":"The PATHFINDER 2 Study: Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population","has_exemption":false,"start_date":"2021-12-08","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"GRAIL, Inc.","sponsor_slug":"grail-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06435026","publication_url":"https://clinicaltrials.gov/study/NCT06435026","title":"Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1","has_exemption":false,"start_date":"2024-06-18","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518239","publication_url":"https://clinicaltrials.gov/study/NCT06518239","title":"Establishing Optimal PEEP Setting for Obese Patients in the Steep Trendelenburg Position: a Pilot Study.","has_exemption":false,"start_date":"2024-11-18","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06488365","publication_url":"https://clinicaltrials.gov/study/NCT06488365","title":"In Vivo Liquid Biopsy for Early Detection of Metastatic Melanoma","has_exemption":false,"start_date":"2025-02-11","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"Cytoastra","sponsor_slug":"cytoastra","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05095376","publication_url":"https://clinicaltrials.gov/study/NCT05095376","title":"A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients With Methylated MGMT Promoter Glioblastoma","has_exemption":false,"start_date":"2022-03-28","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"NRG Oncology","sponsor_slug":"nrg-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05497804","publication_url":"https://clinicaltrials.gov/study/NCT05497804","title":"REsponse Adapted Combination Therapy Approaches for High-Risk Multiple Myeloma (REACH)","has_exemption":false,"start_date":"2022-09-22","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05840159","publication_url":"https://clinicaltrials.gov/study/NCT05840159","title":"A Phase 4 Study of a 3-Day vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection","has_exemption":false,"start_date":"2024-01-19","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625411","publication_url":"https://clinicaltrials.gov/study/NCT06625411","title":"REVEAL-1 - A Phase 3, Randomized, Double-masked, Placebo-controlled, Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)","has_exemption":false,"start_date":"2024-08-27","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Viridian Therapeutics, Inc.","sponsor_slug":"viridian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06685835","publication_url":"https://clinicaltrials.gov/study/NCT06685835","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa - The CEDAR Study","has_exemption":false,"start_date":"2024-12-16","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290595","publication_url":"https://clinicaltrials.gov/study/NCT07290595","title":"Comparative Analysis Of Dexmedetomidine And Dexamethasone As An Adjuvant To 0.5%Ropivacaine On Onset Of Ultrasound Guided Supraclavicular Brachial Plexus Block In Patients Undergoing Upper Limb Surgeries","has_exemption":false,"start_date":"2025-01-13","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Sahiwal medical college sahiwal","sponsor_slug":"sahiwal-medical-college-sahiwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06790121","publication_url":"https://clinicaltrials.gov/study/NCT06790121","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of 3 Subcutaneous Dose Regimens of Lunsekimig (SAR443765) in Adult Participants With Moderate-to-severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-01-30","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06932133","publication_url":"https://clinicaltrials.gov/study/NCT06932133","title":"Breast Point-of-Care Ultrasound Examination Trial","has_exemption":false,"start_date":"2025-04-07","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Region Skane","sponsor_slug":"region-skane","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06941610","publication_url":"https://clinicaltrials.gov/study/NCT06941610","title":"An Evaluation of the Erchonia Corporation GVS Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity on the Abdominal Region","has_exemption":false,"start_date":"2025-05-30","completion_date":"2026-02-12","has_results":true,"results_due":false,"sponsor_name":"Erchonia Corporation","sponsor_slug":"erchonia-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04708834","publication_url":"https://clinicaltrials.gov/study/NCT04708834","title":"A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder","has_exemption":false,"start_date":"2021-03-30","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Biohaven Pharmaceuticals, Inc.","sponsor_slug":"biohaven-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05016245","publication_url":"https://clinicaltrials.gov/study/NCT05016245","title":"A Multicentre, Prospective, Open-label, Randomized Controlled Trial on the Efficacy and Safety of TheraSphereTM (Yttrium-90 Glass Microspheres) Compared to Conventional Transarterial Chemoembolization (cTACE) in Chinese Patients With Inoperable Hepatocellular Carcinoma","has_exemption":false,"start_date":"2021-09-13","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05018299","publication_url":"https://clinicaltrials.gov/study/NCT05018299","title":"A Randomized, Placebo Controlled, Double Blind Phase IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Multiple Intravenous Doses of FB704A in Adults With Severe Asthma","has_exemption":false,"start_date":"2021-09-30","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Oneness Biotech Co., Ltd.","sponsor_slug":"oneness-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05220358","publication_url":"https://clinicaltrials.gov/study/NCT05220358","title":"Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study","has_exemption":false,"start_date":"2022-06-15","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Orlando Immunology Center","sponsor_slug":"orlando-immunology-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05317364","publication_url":"https://clinicaltrials.gov/study/NCT05317364","title":"Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery: a Randomized Clinical Trial","has_exemption":false,"start_date":"2022-07-14","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06270836","publication_url":"https://clinicaltrials.gov/study/NCT06270836","title":"A Prospective, Randomized, Double-masked, Sham-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tarcocimab Tedromer in Participants With Diabetic Retinopathy (DR) - GLOW2","has_exemption":false,"start_date":"2024-05-01","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Kodiak Sciences Inc","sponsor_slug":"kodiak-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04374773","publication_url":"https://clinicaltrials.gov/study/NCT04374773","title":"Effect of Estradiol and Cortisol on Marinol Metabolism","has_exemption":false,"start_date":"2020-10-19","completion_date":"2026-02-14","has_results":true,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04582383","publication_url":"https://clinicaltrials.gov/study/NCT04582383","title":"A Randomized, Double-Blind, Multi-Center Comparative Effectiveness Study of Spironolactone Versus Doxycycline Hyclate for the Treatment of Acne in Women","has_exemption":false,"start_date":"2022-03-30","completion_date":"2026-02-14","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05149768","publication_url":"https://clinicaltrials.gov/study/NCT05149768","title":"An Open Label Extension Study of Brentuximab Vedotin Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Scleroderma)","has_exemption":false,"start_date":"2024-02-14","completion_date":"2026-02-14","has_results":false,"results_due":false,"sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","sponsor_slug":"london-health-sciences-centre-research-institute-or-lawson-research-institute-of-st-josephs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05759013","publication_url":"https://clinicaltrials.gov/study/NCT05759013","title":"A Randomized, Sham Controlled, Double-blinded, Multi-center Trial to Evaluate the Efficacy of the VentFree Respiratory Muscle Stimulator to Assist Ventilator Weaning in Critically Ill Patients","has_exemption":false,"start_date":"2024-02-15","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Liberate Medical","sponsor_slug":"liberate-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06549842","publication_url":"https://clinicaltrials.gov/study/NCT06549842","title":"Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial","has_exemption":false,"start_date":"2024-08-15","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Regional Hospital of Scranton","sponsor_slug":"regional-hospital-of-scranton","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06543303","publication_url":"https://clinicaltrials.gov/study/NCT06543303","title":"A Phase 2, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Efficacy and Safety of Cevimeline Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease","has_exemption":false,"start_date":"2024-12-31","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"BioTheraVision, Inc.","sponsor_slug":"biotheravision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06828666","publication_url":"https://clinicaltrials.gov/study/NCT06828666","title":"A Phase 1/2a, Multicenter, Randomized, Controlled, Single-Blind, Dose-Finding Study to Evaluate the Safety and Efficacy of Cryopreserved Devitalized Adipose Tissue Allograft (BRC-OA) for Pain Treatment in Subjects With Mild to Severe Osteoarthritis (OA) of the Knee","has_exemption":false,"start_date":"2025-05-05","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Britecyte","sponsor_slug":"britecyte","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07084363","publication_url":"https://clinicaltrials.gov/study/NCT07084363","title":"Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery (The QUANTUM Trial): Single-center Cluster Randomized Multiple Crossover Trial","has_exemption":false,"start_date":"2025-09-22","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07148999","publication_url":"https://clinicaltrials.gov/study/NCT07148999","title":"An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for PPOS","has_exemption":false,"start_date":"2025-09-23","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Urmila DIwekar","sponsor_slug":"urmila-diwekar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219316","publication_url":"https://clinicaltrials.gov/study/NCT07219316","title":"Regenerative High Purity Type I Collagen Scaffold for Breast Cancer Excision Repair and Reconstruction: A Prospective Multicenter Clinical Trial","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-02-15","has_results":true,"results_due":false,"sponsor_name":"Adichunchanagiri Institute of Medical Sciences, B G Nagara","sponsor_slug":"adichunchanagiri-institute-of-medical-sciences-b-g-nagara","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07344038","publication_url":"https://clinicaltrials.gov/study/NCT07344038","title":"Effectiveness of Bioceramic Calcium Silicate-based Pulpotomy Medicament on Primary Molars Restored With 3d Printed Resin Crowns (a Randomized Controlled Clinical Trial)","has_exemption":false,"start_date":"2026-01-20","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Alexandria University","sponsor_slug":"alexandria-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03066206","publication_url":"https://clinicaltrials.gov/study/NCT03066206","title":"A Phase II Study of Poziotinib in EGFR or HER2 Mutant Advanced Solid Tumors","has_exemption":false,"start_date":"2017-03-17","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03661320","publication_url":"https://clinicaltrials.gov/study/NCT03661320","title":"A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy Alone Versus Neoadjuvant Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post- Surgery Therapy With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle- Invasive Bladder Cancer","has_exemption":false,"start_date":"2018-11-06","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03875638","publication_url":"https://clinicaltrials.gov/study/NCT03875638","title":"Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition","has_exemption":false,"start_date":"2019-08-22","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05628805","publication_url":"https://clinicaltrials.gov/study/NCT05628805","title":"Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome","has_exemption":false,"start_date":"2022-11-01","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06314490","publication_url":"https://clinicaltrials.gov/study/NCT06314490","title":"Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A","has_exemption":false,"start_date":"2024-02-16","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05621616","publication_url":"https://clinicaltrials.gov/study/NCT05621616","title":"A Phase 3, Open Label, Multicenter, Baseline-Controlled Sequential Dose Titration Study Followed by a Fixed Dose Observation Period to Evaluate Pharmacokinetics, Efficacy and Safety of Mirabegron Prolonged-Release Microgranula-Based Suspension in Children From 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity","has_exemption":false,"start_date":"2024-02-28","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721572","publication_url":"https://clinicaltrials.gov/study/NCT06721572","title":"Role of Home-Based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis (TEA-CuP): A Double-Blind, Sham-Controlled Crossover Trial","has_exemption":false,"start_date":"2025-01-13","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06844669","publication_url":"https://clinicaltrials.gov/study/NCT06844669","title":"HER2HEART-US: Primary Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy: a Pilot 2x2 Factorial Randomized Controlled Trial","has_exemption":false,"start_date":"2025-04-16","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07136766","publication_url":"https://clinicaltrials.gov/study/NCT07136766","title":"An 18 Week Study to Assess the Efficacy of a Test Product Used in Combination With a Currently Marketed Prescription Product","has_exemption":false,"start_date":"2025-09-10","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Good Molecules, LLC","sponsor_slug":"good-molecules-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02444741","publication_url":"https://clinicaltrials.gov/study/NCT02444741","title":"Phase I/II Trial of MK-3475 and Hypofractionated Stereotactic Radiation Therapy in Patients With NSCLC","has_exemption":false,"start_date":"2015-09-17","completion_date":"2026-02-17","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT07597239","publication_url":"https://clinicaltrials.gov/study/NCT07597239","title":"The Use of Thromboelastography With Platelet Mapping to Guide Thromboprophylaxis Following Lower Extremity Revascularization for Peripheral Artery Disease","has_exemption":false,"start_date":"2022-12-14","completion_date":"2026-02-17","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06018558","publication_url":"https://clinicaltrials.gov/study/NCT06018558","title":"A Phase 1/2 Study to Assess the Safety And Efficacy Of OCU410 For Geographic Atrophy Secondary To Dry Age-Related Macular Degeneration","has_exemption":false,"start_date":"2023-02-23","completion_date":"2026-02-17","has_results":false,"results_due":false,"sponsor_name":"Ocugen","sponsor_slug":"ocugen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06293365","publication_url":"https://clinicaltrials.gov/study/NCT06293365","title":"A Randomized, Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL Pre-filled Syringe With 1 mL Pre-filled Syringe in Adult Participants With Autoimmune Disease","has_exemption":false,"start_date":"2024-07-02","completion_date":"2026-02-17","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06162663","publication_url":"https://clinicaltrials.gov/study/NCT06162663","title":"Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors","has_exemption":false,"start_date":"2024-09-20","completion_date":"2026-02-17","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06317220","publication_url":"https://clinicaltrials.gov/study/NCT06317220","title":"Vedolizumab for the Treatment of Collagenous Gastritis","has_exemption":false,"start_date":"2024-12-03","completion_date":"2026-02-17","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04350138","publication_url":"https://clinicaltrials.gov/study/NCT04350138","title":"A Phase II Randomized, Observer-Blind, Placebo-Controlled Study, to Assess the Efficacy of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) in Preventing Gonococcal Infection","has_exemption":false,"start_date":"2020-12-29","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04821622","publication_url":"https://clinicaltrials.gov/study/NCT04821622","title":"TALAPRO-3: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, STUDY OF TALAZOPARIB WITH ENZALUTAMIDE VERSUS PLACEBO WITH ENZALUTAMIDE IN MEN WITH DDR GENE MUTATED METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER","has_exemption":false,"start_date":"2021-05-12","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04965597","publication_url":"https://clinicaltrials.gov/study/NCT04965597","title":"Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases","has_exemption":false,"start_date":"2022-04-19","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05831176","publication_url":"https://clinicaltrials.gov/study/NCT05831176","title":"A Phase 2, 2-Part, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis","has_exemption":false,"start_date":"2023-05-03","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569238","publication_url":"https://clinicaltrials.gov/study/NCT06569238","title":"The Role of the Microbiome in Diabetic Foot Ulcers","has_exemption":false,"start_date":"2024-09-05","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630559","publication_url":"https://clinicaltrials.gov/study/NCT06630559","title":"A Randomized, Active-Controlled, Double-Blind, Phase 3 Study to Compare Efficacy and Safety of CT-P55 With Cosentyx in Patients With Moderate to Severe Plaque Psoriasis","has_exemption":false,"start_date":"2025-05-26","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"Celltrion","sponsor_slug":"celltrion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04205838","publication_url":"https://clinicaltrials.gov/study/NCT04205838","title":"IL-1 Receptor Antagonist to Prevent Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome","has_exemption":false,"start_date":"2020-03-04","completion_date":"2026-02-19","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04471844","publication_url":"https://clinicaltrials.gov/study/NCT04471844","title":"EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2020-12-08","completion_date":"2026-02-19","has_results":false,"results_due":false,"sponsor_name":"NovoCure Ltd.","sponsor_slug":"novocure-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05240807","publication_url":"https://clinicaltrials.gov/study/NCT05240807","title":"Comprehensive Characterization of Coronary Atherosclerotic Disease Using Photon-counting Detector Dual-source CT and Its Impact on Patient Management","has_exemption":false,"start_date":"2022-08-24","completion_date":"2026-02-19","has_results":true,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05848011","publication_url":"https://clinicaltrials.gov/study/NCT05848011","title":"A Phase 2, Randomized, Open-Label, Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2023-09-28","completion_date":"2026-02-19","has_results":false,"results_due":false,"sponsor_name":"MacroGenics","sponsor_slug":"macrogenics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06637072","publication_url":"https://clinicaltrials.gov/study/NCT06637072","title":"A Phase 4, Open-Label, Single-Group, Multicenter Study in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy Who Transition From Treatment With Intravenous Immunoglobulin to Efgartigimod PH20 SC","has_exemption":false,"start_date":"2024-12-10","completion_date":"2026-02-19","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03288545","publication_url":"https://clinicaltrials.gov/study/NCT03288545","title":"A Study of Enfortumab Vedotin (ASG-22CE) as Monotherapy or in Combination With Other Anticancer Therapies for the Treatment of Urothelial Cancer","has_exemption":false,"start_date":"2017-10-11","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03645928","publication_url":"https://clinicaltrials.gov/study/NCT03645928","title":"A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN 144/LN-145/LN-145-S1) in Patients With Solid Tumors","has_exemption":false,"start_date":"2019-05-07","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Iovance Biotherapeutics, Inc.","sponsor_slug":"iovance-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04562389","publication_url":"https://clinicaltrials.gov/study/NCT04562389","title":"A Phase 1/3 Study to Evaluate Efficacy and Safety of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Ruxolitinib in Treatment-naïve Patients With Myelofibrosis","has_exemption":false,"start_date":"2021-03-11","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04852783","publication_url":"https://clinicaltrials.gov/study/NCT04852783","title":"US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair","has_exemption":false,"start_date":"2021-08-06","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Cerus Endovascular, Inc.","sponsor_slug":"cerus-endovascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04820179","publication_url":"https://clinicaltrials.gov/study/NCT04820179","title":"Phase II Trial Evaluating the Safety and Efficacy of Atezolizumab in Combination With Cabozantinib for the Treatment of Metastatic, Refractory Pancreatic Cancer","has_exemption":false,"start_date":"2021-10-12","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05127109","publication_url":"https://clinicaltrials.gov/study/NCT05127109","title":"The PASTDUe Nutrition EcoSystem Pathway In Acute Care Abdominal Surgery and Trauma to Decrease Underfeeding and Complications","has_exemption":false,"start_date":"2022-04-25","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05648968","publication_url":"https://clinicaltrials.gov/study/NCT05648968","title":"A Phase 3, Randomized, Double-blind, Study to Assess Efficacy and Safety of Ianalumab (VAY736) Versus Placebo in Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Who Failed at Least One Line of Treatment","has_exemption":false,"start_date":"2022-12-30","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05988918","publication_url":"https://clinicaltrials.gov/study/NCT05988918","title":"A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors","has_exemption":false,"start_date":"2024-04-19","completion_date":"2026-02-21","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02719613","publication_url":"https://clinicaltrials.gov/study/NCT02719613","title":"Continuing Treatment for Subjects Who Have Participated in a Prior Protocol Investigating Elotuzumab","has_exemption":false,"start_date":"2016-07-15","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04974398","publication_url":"https://clinicaltrials.gov/study/NCT04974398","title":"A Randomized, Double-blind, Multi-center Phase III Study of Penpulimab (AK105) Combined With Chemotherapy Versus Placebo Combined With Chemotherapy in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma","has_exemption":false,"start_date":"2021-08-16","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Akeso","sponsor_slug":"akeso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05301842","publication_url":"https://clinicaltrials.gov/study/NCT05301842","title":"A Phase III, Randomized, Open-Label, Sponsor-Blinded, Multicenter Study of Durvalumab in Combination With Tremelimumab ± Lenvatinib Given Concurrently With TACE Compared to TACE Alone in Patients With Locoregional Hepatocellular Carcinoma (EMERALD-3)","has_exemption":false,"start_date":"2022-03-28","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04983030","publication_url":"https://clinicaltrials.gov/study/NCT04983030","title":"A Safety, Immunogenicity and Efficacy Phase 1/2a Study of a Heterologous Ad26.Mos4.HIV, MVA-BN-HIV Vaccine Regimen Plus Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults on Suppressive ART","has_exemption":false,"start_date":"2022-04-01","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Boris Juelg, MD PhD","sponsor_slug":"boris-juelg-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05811351","publication_url":"https://clinicaltrials.gov/study/NCT05811351","title":"A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2023-03-06","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827002","publication_url":"https://clinicaltrials.gov/study/NCT06827002","title":"Cissus Quadrangularis (CQR-300®) and Dichrostachys Glomerata (Dyglomera®) Extracts Increase GLP-1 Levels and Inhibit Dipeptidyl Phosphate-4 Activity in Healthy Overweight and Obese Adults","has_exemption":false,"start_date":"2023-03-29","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"University of Yaounde 1","sponsor_slug":"university-of-yaounde-1","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06102005","publication_url":"https://clinicaltrials.gov/study/NCT06102005","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With Moderate-to-severe Asthma","has_exemption":false,"start_date":"2023-10-16","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06603077","publication_url":"https://clinicaltrials.gov/study/NCT06603077","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa (LOTUS)","has_exemption":false,"start_date":"2024-09-16","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Avalo Therapeutics, Inc.","sponsor_slug":"avalo-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06558799","publication_url":"https://clinicaltrials.gov/study/NCT06558799","title":"LUNAR-4: Pilot, Single Arm, Open-Label, Multinational Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) Previously Treated With a PD-1/PD-L1 Inhibitor and Platinum-Based Chemotherapy","has_exemption":false,"start_date":"2024-10-14","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"NovoCure GmbH","sponsor_slug":"novocure-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06836063","publication_url":"https://clinicaltrials.gov/study/NCT06836063","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate Efficacy and Safety of Ropanicant in Patients With Major Depressive Disorder","has_exemption":false,"start_date":"2025-07-15","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Suven Life Sciences Limited","sponsor_slug":"suven-life-sciences-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06030193","publication_url":"https://clinicaltrials.gov/study/NCT06030193","title":"A Randomized, Active-controlled, Multi-site, Double-masked, Pilot Study to Evaluate the Safety and Tolerability of QLS-111 Versus Timolol Maleate Preservative Free 0.5% Ophthalmic Solution in Subjects With Normal Tension Glaucoma (NTG)","has_exemption":false,"start_date":"2025-08-13","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Qlaris Bio, Inc.","sponsor_slug":"qlaris-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04963283","publication_url":"https://clinicaltrials.gov/study/NCT04963283","title":"A Phase II Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer","has_exemption":false,"start_date":"2021-06-23","completion_date":"2026-02-24","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05598723","publication_url":"https://clinicaltrials.gov/study/NCT05598723","title":"A Randomized, Double-Blind Study on the Effect of OnabotulinumtoxinA (BOTOX®) vs. IncobotulinumtoxinA (XEOMIN®) Botulinum Toxin in Adults With Chronic Migraine","has_exemption":false,"start_date":"2023-02-24","completion_date":"2026-02-24","has_results":false,"results_due":false,"sponsor_name":"Naval Medical Center Camp Lejeune","sponsor_slug":"naval-medical-center-camp-lejeune","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06113445","publication_url":"https://clinicaltrials.gov/study/NCT06113445","title":"A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo","has_exemption":false,"start_date":"2023-11-29","completion_date":"2026-02-24","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06563102","publication_url":"https://clinicaltrials.gov/study/NCT06563102","title":"A 12-week, Randomized, Double-Blind, Phase 4 Study Evaluating the Effect of AIRSUPRA Compared to Albuterol Administered as Needed on Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization in Adults With Mild Asthma","has_exemption":false,"start_date":"2024-09-11","completion_date":"2026-02-24","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04016376","publication_url":"https://clinicaltrials.gov/study/NCT04016376","title":"Cluster-Randomized, Prospective Assessment of Postoperative Pain Management in Patients Undergoing Bilateral Mastectomy With Immediate Reconstruction With Tissue Expander (BMWRw/TE) Using Preoperative Paravertebral (PVB), Serratus+PECS-1, or PVB+PECS-1 Nerve Blocks","has_exemption":false,"start_date":"2019-07-05","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04039347","publication_url":"https://clinicaltrials.gov/study/NCT04039347","title":"A Phase III, Extension Clinical Trial to Demonstrate Efficacy and Safety of Liposomal Cyclosprine A Via the PARI Investigational eFlow® Device and SoC in Treating Bronchiolitis Obliterans in Patients Post Single or Double Lung Transplant","has_exemption":false,"start_date":"2020-03-12","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Zambon SpA","sponsor_slug":"zambon-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04343573","publication_url":"https://clinicaltrials.gov/study/NCT04343573","title":"A Phase II Randomized Study Assessing the Efficacy of Proton Craniospinal Irradiation (CSI) vs Involved-field Photon Radiation Therapy for Leptomeningeal Metastases From Solid Tumor Malignancies","has_exemption":false,"start_date":"2020-04-10","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04211935","publication_url":"https://clinicaltrials.gov/study/NCT04211935","title":"The Use of Video-assisted Intercostal Nerve Cryoablation, Erector Spinae Block, and Thoracic Epidural for Postoperative Analgesia After Minimally Invasive Repair of Pectus Excavatum","has_exemption":false,"start_date":"2020-05-27","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04711148","publication_url":"https://clinicaltrials.gov/study/NCT04711148","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Biological Activity","has_exemption":false,"start_date":"2021-03-01","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Beijing InnoCare Pharma Tech Co., Ltd.","sponsor_slug":"beijing-innocare-pharma-tech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05975073","publication_url":"https://clinicaltrials.gov/study/NCT05975073","title":"A Phase 1/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Anvumetostat in Combination With IDE397 in Subjects With Advanced MTAP-null Solid Tumors","has_exemption":false,"start_date":"2023-08-01","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996835","publication_url":"https://clinicaltrials.gov/study/NCT05996835","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Four-arm, Parallel-group, Dose-finding Phase 2b Study to Investigate the Safety and Efficacy of TIN816 Via a Single Intravenous Infusion in the Treatment of Participants With Sepsis-associated Acute Kidney Injury (CLEAR-AKI)","has_exemption":false,"start_date":"2024-01-18","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07077044","publication_url":"https://clinicaltrials.gov/study/NCT07077044","title":"Transcutaneous Electrical Nerve Stimulation in Children With Functional Constipation Monitored by Pocket-sized Point-of-care Ultrasound.","has_exemption":false,"start_date":"2024-02-21","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Hadassah Medical Organization","sponsor_slug":"hadassah-medical-organization","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06585423","publication_url":"https://clinicaltrials.gov/study/NCT06585423","title":"Tolerability of an Anesthesia-free Tonometer Tip","has_exemption":false,"start_date":"2024-10-17","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06853990","publication_url":"https://clinicaltrials.gov/study/NCT06853990","title":"A Single-arm Trial With an Innovative Automated Insulin Delivery System for Type 2 Diabetes (\"Twiist-T2D\")","has_exemption":false,"start_date":"2025-04-14","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Deka Research and Development","sponsor_slug":"deka-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07120945","publication_url":"https://clinicaltrials.gov/study/NCT07120945","title":"A Prospective, Multicenter, Single-arm Pre-market Study of the Medtronic Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)","has_exemption":false,"start_date":"2025-08-28","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07058909","publication_url":"https://clinicaltrials.gov/study/NCT07058909","title":"Premarket Clinical Safety Assessment of the ELISIO™-HX","has_exemption":false,"start_date":"2025-09-08","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Nipro Medical Corporation","sponsor_slug":"nipro-medical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02154568","publication_url":"https://clinicaltrials.gov/study/NCT02154568","title":"Flow Quantification in the Human Airways Using Hyperpolarized Helium 3 MRI","has_exemption":false,"start_date":"2013-11-07","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04785287","publication_url":"https://clinicaltrials.gov/study/NCT04785287","title":"Phase I/II Trial of Anti-CTLA4-NF mAb (BMS-986218) in Combination With Nivolumab and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid Malignancies","has_exemption":false,"start_date":"2021-03-29","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04709276","publication_url":"https://clinicaltrials.gov/study/NCT04709276","title":"A Phase II, Single Arm Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)","has_exemption":false,"start_date":"2021-06-07","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"Andrew J. Armstrong, MD","sponsor_slug":"andrew-j-armstrong-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05742802","publication_url":"https://clinicaltrials.gov/study/NCT05742802","title":"A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) With a History of Exacerbations (PROSPERO).","has_exemption":false,"start_date":"2023-03-06","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05597878","publication_url":"https://clinicaltrials.gov/study/NCT05597878","title":"Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-04-18","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05681884","publication_url":"https://clinicaltrials.gov/study/NCT05681884","title":"Faricimab for Retinal Non-Perfusion Associated With Non-Proliferative Diabetic Retinopathy: The MAGIC Phase 2, Multi-Center, Open-Label, Randomized Controlled Trial","has_exemption":false,"start_date":"2023-05-16","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"Greater Houston Retina Research","sponsor_slug":"greater-houston-retina-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04777851","publication_url":"https://clinicaltrials.gov/study/NCT04777851","title":"A Phase III, Multicenter, Randomized, Open-label Trial to Evaluate the Safety and Efficacy of Systemic Therapy With Regorafenib and Pembrolizumab Versus Locoregional Therapy With Transarterial Chemoembolization or Transarterial Radioembolization, for the First-line Treatment of Intermediate-stage Hepatocellular Carcinoma With Beyond Up-to-7 Criteria","has_exemption":false,"start_date":"2023-10-11","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"Translational Research in Oncology","sponsor_slug":"translational-research-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06404112","publication_url":"https://clinicaltrials.gov/study/NCT06404112","title":"RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)","has_exemption":false,"start_date":"2024-07-31","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03383458","publication_url":"https://clinicaltrials.gov/study/NCT03383458","title":"A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab Versus Placebo for Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation","has_exemption":false,"start_date":"2018-04-18","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05230732","publication_url":"https://clinicaltrials.gov/study/NCT05230732","title":"Neuromodulation of Inflammation and Endothelial Function to Treat Elderly Patients With Systolic Heart Failure","has_exemption":false,"start_date":"2022-09-01","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05378399","publication_url":"https://clinicaltrials.gov/study/NCT05378399","title":"SmartSteps: A Context-Aware, Pre-Exposure Prophylaxis Adherence Intervention for Individuals With Substance Use Disorder","has_exemption":false,"start_date":"2022-12-20","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05123040","publication_url":"https://clinicaltrials.gov/study/NCT05123040","title":"Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids for Treatment of Minnesota High-Risk Acute GVHD (aGVHD): A Phase I/II Study","has_exemption":false,"start_date":"2023-06-05","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06134648","publication_url":"https://clinicaltrials.gov/study/NCT06134648","title":"A Phase I/IIa, Randomized, Observer-blind Placebo-controlled Multi-arm Study to Evaluate the Safety and Immunogenicity of an RSV/hMPV Vaccine, in Adult Participants Aged 60 Years and Older","has_exemption":false,"start_date":"2023-11-01","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05982171","publication_url":"https://clinicaltrials.gov/study/NCT05982171","title":"Transcutaneous Spinal Cord Stimulation to Promote Walking Recovery After Spinal Cord Injury","has_exemption":false,"start_date":"2023-11-15","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Craig Hospital","sponsor_slug":"craig-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06341712","publication_url":"https://clinicaltrials.gov/study/NCT06341712","title":"A Phase II, Randomized, Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics (PK) of Maintenance Cabozantinib (XL184) Plus Best Supportive Care (BSC) Versus BSC in Children, Adolescents and Young Adults (AYA) With Unresectable Residual Osteosarcoma Either at Diagnosis or at First Relapse After Standard Treatment","has_exemption":false,"start_date":"2024-11-22","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06617338","publication_url":"https://clinicaltrials.gov/study/NCT06617338","title":"Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty","has_exemption":false,"start_date":"2024-12-12","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06819033","publication_url":"https://clinicaltrials.gov/study/NCT06819033","title":"Effects of Photobiomodulation on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06948760","publication_url":"https://clinicaltrials.gov/study/NCT06948760","title":"Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D [Launchpad Lyumjev]","has_exemption":false,"start_date":"2025-07-23","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Mark D. DeBoer, MD, MSc., MCR","sponsor_slug":"mark-d-deboer-md-msc-mcr","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07263698","publication_url":"https://clinicaltrials.gov/study/NCT07263698","title":"Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash - a Three-month Study in Italy","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03621553","publication_url":"https://clinicaltrials.gov/study/NCT03621553","title":"Vitamin D Homeostasis in Sarcoidosis","has_exemption":false,"start_date":"2010-07-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01917721","publication_url":"https://clinicaltrials.gov/study/NCT01917721","title":"Phase 2 Study to Assess the Efficacy and Safety of Doxycycline in Preventing Coronary Artery Aneurysm Formation and Progression","has_exemption":false,"start_date":"2013-10-31","completion_date":"2026-02-28","has_results":true,"results_due":false,"sponsor_name":"Hawaii Pacific Health","sponsor_slug":"hawaii-pacific-health","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02735707","publication_url":"https://clinicaltrials.gov/study/NCT02735707","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","has_exemption":false,"start_date":"2016-04-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"UMC Utrecht","sponsor_slug":"umc-utrecht","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02481245","publication_url":"https://clinicaltrials.gov/study/NCT02481245","title":"A Pan-PPAR Agonist Treatment for Bipolar Depression: A Proof of Concept Study","has_exemption":false,"start_date":"2018-01-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03348995","publication_url":"https://clinicaltrials.gov/study/NCT03348995","title":"A Prospective Cohort Clinical Trial Evaluating Age as a Risk Factor for Poor Outcomes of Bridge-Enhanced ACL Restoration (BEAR)","has_exemption":false,"start_date":"2018-04-17","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Miach Orthopaedics","sponsor_slug":"miach-orthopaedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03544632","publication_url":"https://clinicaltrials.gov/study/NCT03544632","title":"A Phase II, Dose-escalation, Open-label Study Evaluating the Safety and Efficacy of Permanently-placed Acellular Adipose Tissue (AAT) in Human Subjects With Modest Soft Tissue Defects of the Trunk","has_exemption":false,"start_date":"2018-06-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03527472","publication_url":"https://clinicaltrials.gov/study/NCT03527472","title":"A Randomized Placebo-controlled, Double Blind Phase 2 Clinical Trial of Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2018-08-23","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03629340","publication_url":"https://clinicaltrials.gov/study/NCT03629340","title":"Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction","has_exemption":false,"start_date":"2019-02-26","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03796559","publication_url":"https://clinicaltrials.gov/study/NCT03796559","title":"A Prospective Open Label Study of the Use of Magseed® Markers and Sentimag® to Localize Axillary Lymph Nodes with Biopsy-proven Metastases in Breast Cancer Patients","has_exemption":false,"start_date":"2019-06-13","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Endomagnetics Ltd.","sponsor_slug":"endomagnetics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03879629","publication_url":"https://clinicaltrials.gov/study/NCT03879629","title":"TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol (TACTIC) Trial","has_exemption":false,"start_date":"2019-08-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04517565","publication_url":"https://clinicaltrials.gov/study/NCT04517565","title":"Longitudinal Neuroimaging in Sturge-Weber Syndrome","has_exemption":false,"start_date":"2020-03-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Wayne State University","sponsor_slug":"wayne-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04137107","publication_url":"https://clinicaltrials.gov/study/NCT04137107","title":"Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study","has_exemption":false,"start_date":"2020-06-17","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04432623","publication_url":"https://clinicaltrials.gov/study/NCT04432623","title":"A Phase 1b Sequential Open Label Dose-Ranging Study of Safety, Pharmacokinetics, and Preliminary Activity of Benserazide in Subjects With Beta Thalassemia Intermedia and Sickle Cell Disease","has_exemption":false,"start_date":"2020-10-05","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Phoenicia BioScience","sponsor_slug":"phoenicia-bioscience","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04103879","publication_url":"https://clinicaltrials.gov/study/NCT04103879","title":"A Phase II Open-Label Study of UM171-Expanded Cord Blood Transplantation in Patients With High and Very High Risk Acute Leukemia/Myelodysplasia","has_exemption":false,"start_date":"2020-11-13","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"ExCellThera inc.","sponsor_slug":"excellthera-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04788823","publication_url":"https://clinicaltrials.gov/study/NCT04788823","title":"The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal: A Randomized, Controlled Trial","has_exemption":false,"start_date":"2021-02-24","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Charitable Union for the Research and Education of Peyronie's Disease","sponsor_slug":"charitable-union-for-the-research-and-education-of-peyronies-disease","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04520776","publication_url":"https://clinicaltrials.gov/study/NCT04520776","title":"A Multicenter, Prospective, Randomized, Clinical Trial Comparing the Safety and Effectiveness of the BAGUERA C Cervical Disc Prosthesis to the Mobi-C® Cervical Disc for the Treatment of Patients With Symptomatic Cervical Disc Disease at a Single Level","has_exemption":false,"start_date":"2021-03-02","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Spineart USA","sponsor_slug":"spineart-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04713475","publication_url":"https://clinicaltrials.gov/study/NCT04713475","title":"Phase 1/2 Open-Label, Multicenter Study to Assess the Safety, Tolerability and Efficacy of a Single Dose of PBGM01 Delivered Into the Cisterna Magna of Pediatric Type 1 (Early Onset) and Type 2a (Late Onset) Infantile GM1 Gangliosidosis","has_exemption":false,"start_date":"2021-03-17","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Gemma Biotherapeutics","sponsor_slug":"gemma-biotherapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05159765","publication_url":"https://clinicaltrials.gov/study/NCT05159765","title":"Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial","has_exemption":false,"start_date":"2022-01-22","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Visioneering Technologies, Inc","sponsor_slug":"visioneering-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04711824","publication_url":"https://clinicaltrials.gov/study/NCT04711824","title":"Phase I/II Study of Stereotactic Radiosurgery With Concurrent Administration of DNA Damage Response (DDR) Inhibitor (OLAparib) Followed by Adjuvant Combination of DuRvalumab (MEDI4736) and Physician's Choice Systemic Therapy in Subjects With BreAst Cancer Brain Metastases","has_exemption":false,"start_date":"2022-03-09","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Colette Shen","sponsor_slug":"colette-shen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05308446","publication_url":"https://clinicaltrials.gov/study/NCT05308446","title":"Randomized Phase II Trial of Encorafenib and Cetuximab With or Without Nivolumab (NSC #748726) for Patients With Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer","has_exemption":false,"start_date":"2022-07-19","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05325645","publication_url":"https://clinicaltrials.gov/study/NCT05325645","title":"A Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Investigate the Efficacy and Safety of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia","has_exemption":false,"start_date":"2022-07-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","sponsor_slug":"otsuka-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07024342","publication_url":"https://clinicaltrials.gov/study/NCT07024342","title":"Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration","has_exemption":false,"start_date":"2022-10-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"VA Puget Sound Health Care System","sponsor_slug":"va-puget-sound-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05468489","publication_url":"https://clinicaltrials.gov/study/NCT05468489","title":"A Randomized, Open-label Study of Serplulimab Plus Chemotherapy (Carboplatin-Etoposide) in Comparison With Atezolizumab Plus Chemotherapy in Previously Untreated US Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) (ASTRIDE)","has_exemption":false,"start_date":"2022-11-18","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Shanghai Henlius Biotech","sponsor_slug":"shanghai-henlius-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05470205","publication_url":"https://clinicaltrials.gov/study/NCT05470205","title":"Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension","has_exemption":false,"start_date":"2022-11-28","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05525247","publication_url":"https://clinicaltrials.gov/study/NCT05525247","title":"A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination With Various Anticancer Therapies in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-12-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Selecxine","sponsor_slug":"selecxine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05693142","publication_url":"https://clinicaltrials.gov/study/NCT05693142","title":"A Phase 1/2/3 Open-label Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics, and Pharmacokinetics of Intravenous RGX-202 Gene Therapy in Males With Duchenne Muscular Dystrophy (DMD)","has_exemption":false,"start_date":"2023-01-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Regenxbio Inc.","sponsor_slug":"regenxbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05711940","publication_url":"https://clinicaltrials.gov/study/NCT05711940","title":"A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression","has_exemption":false,"start_date":"2023-02-14","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"COMPASS Pathways","sponsor_slug":"compass-pathways","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05547165","publication_url":"https://clinicaltrials.gov/study/NCT05547165","title":"Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants","has_exemption":false,"start_date":"2023-02-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05805449","publication_url":"https://clinicaltrials.gov/study/NCT05805449","title":"The BIO RAMP Trial - BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma","has_exemption":false,"start_date":"2023-02-21","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05652218","publication_url":"https://clinicaltrials.gov/study/NCT05652218","title":"REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT), a Phase I Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2023-02-26","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02361554","publication_url":"https://clinicaltrials.gov/study/NCT02361554","title":"Deep Brain Stimulation in Treatment Resistant Schizophrenia","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05768919","publication_url":"https://clinicaltrials.gov/study/NCT05768919","title":"Phase I/II Study of the Tolerability, Safety, and Efficacy of Liposomal Curcumin in Combination With Radiation and Temozolomide in Patients With Newly Diagnosed High-Grade Gliomas","has_exemption":false,"start_date":"2023-03-03","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"SignPath Pharma, Inc.","sponsor_slug":"signpath-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05136820","publication_url":"https://clinicaltrials.gov/study/NCT05136820","title":"Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study","has_exemption":false,"start_date":"2023-03-09","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Occlutech International AB","sponsor_slug":"occlutech-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05201404","publication_url":"https://clinicaltrials.gov/study/NCT05201404","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis","has_exemption":false,"start_date":"2023-03-15","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Can-Fite BioPharma","sponsor_slug":"can-fite-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05753215","publication_url":"https://clinicaltrials.gov/study/NCT05753215","title":"Omadacycline Versus Standard-of-Care Oral Antibiotic Treatment for Bone and Joint Infections: An Open-Label, Non- Inferiority, Randomized, Controlled Trial","has_exemption":false,"start_date":"2023-05-09","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","sponsor_slug":"lundquist-institute-for-biomedical-innovation-at-harbor-ucla-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05141149","publication_url":"https://clinicaltrials.gov/study/NCT05141149","title":"A First in Human, Phase 1/2a, Multicentre, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of PBP1510 in Patients With Advanced/Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2023-06-05","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Prestige Biopharma Limited","sponsor_slug":"prestige-biopharma-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05350371","publication_url":"https://clinicaltrials.gov/study/NCT05350371","title":"Evaluation of Pirfenidone as a Therapy in Patients With Predicted Moderate to Severe Acute Pancreatitis","has_exemption":false,"start_date":"2023-08-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003036","publication_url":"https://clinicaltrials.gov/study/NCT06003036","title":"Accelerated Neuromodulation of Prefrontal Circuitry During Clozapine Treatment","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Deepak K. Sarpal, M.D.","sponsor_slug":"deepak-k-sarpal-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05094037","publication_url":"https://clinicaltrials.gov/study/NCT05094037","title":"Orthotic Treatment of Diabetic Foot Ulcers: Patient Adherence to Prescribed Wear and Effectiveness of Treatment","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06009926","publication_url":"https://clinicaltrials.gov/study/NCT06009926","title":"Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Broccoli Seed and Sprout Extract (BSSE) to Evaluate Detoxification of Carcinogens in Firefighters","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976789","publication_url":"https://clinicaltrials.gov/study/NCT05976789","title":"A Feasibility Study of a Novel, Fully Remote Counseling and Sound Therapy Program for Hyperacusis","has_exemption":false,"start_date":"2023-12-18","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Augustana College","sponsor_slug":"augustana-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06265428","publication_url":"https://clinicaltrials.gov/study/NCT06265428","title":"A Phase III, Multicenter, Open-label, Randomized Study to Compare DB-1303 Versus T-DM1 in Patients With HER2-positive Unresectable/Metastatic Breast Cancer Who Have Been Treated With Trastuzumab and a Taxane (Dynasty-Breast01)","has_exemption":false,"start_date":"2024-01-29","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288021","publication_url":"https://clinicaltrials.gov/study/NCT07288021","title":"Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)","has_exemption":false,"start_date":"2024-02-05","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Bnai Zion Medical Center","sponsor_slug":"bnai-zion-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05975983","publication_url":"https://clinicaltrials.gov/study/NCT05975983","title":"A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"InSilico Medicine Hong Kong Limited","sponsor_slug":"insilico-medicine-hong-kong-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06217328","publication_url":"https://clinicaltrials.gov/study/NCT06217328","title":"A Prospective Randomized Control Trial to Compare the Efficacy of the Revi System Therapy on Versus Off in Relieving Urinary Urge Incontinence Episodes.","has_exemption":false,"start_date":"2024-02-24","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"BlueWind Medical","sponsor_slug":"bluewind-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06258486","publication_url":"https://clinicaltrials.gov/study/NCT06258486","title":"Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks","has_exemption":false,"start_date":"2024-02-29","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Kaiser Permanente","sponsor_slug":"kaiser-permanente","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06327451","publication_url":"https://clinicaltrials.gov/study/NCT06327451","title":"Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Tianjin Medical University General Hospital","sponsor_slug":"tianjin-medical-university-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05907330","publication_url":"https://clinicaltrials.gov/study/NCT05907330","title":"A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 Study to Evaluate the Efficacy and Safety of CU104 in Patients With Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2024-06-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Curacle Co., Ltd.","sponsor_slug":"curacle-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06502964","publication_url":"https://clinicaltrials.gov/study/NCT06502964","title":"Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment","has_exemption":false,"start_date":"2024-06-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Alto Neuroscience","sponsor_slug":"alto-neuroscience","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05876078","publication_url":"https://clinicaltrials.gov/study/NCT05876078","title":"DORAYA-HF EU: Assessment of the Doraya Catheter for the Treatment of Volume Overload in Acute Heart Failure Patients With Insufficient Response to Diuretics","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Revamp Medical Ltd.","sponsor_slug":"revamp-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06724614","publication_url":"https://clinicaltrials.gov/study/NCT06724614","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-dose Study to Evaluate the Efficacy and Safety of VDPHL01 in Male Subjects With Androgenetic Alopecia","has_exemption":false,"start_date":"2024-11-06","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Veradermics, Inc.","sponsor_slug":"veradermics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06658574","publication_url":"https://clinicaltrials.gov/study/NCT06658574","title":"Comparative Efficacy of Two Different Oral Dosage Forms of Acetaminophen for Post-operative Analgesia in Bariatric Surgery Patients","has_exemption":false,"start_date":"2024-11-13","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06568471","publication_url":"https://clinicaltrials.gov/study/NCT06568471","title":"A Randomized, Double-blind, Placebo-controlled Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia","has_exemption":false,"start_date":"2024-11-16","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Hasten Biopharmaceutical Co., Ltd.","sponsor_slug":"hasten-biopharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07245667","publication_url":"https://clinicaltrials.gov/study/NCT07245667","title":"Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis","has_exemption":false,"start_date":"2024-12-30","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Propedix, Inc.","sponsor_slug":"propedix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06786884","publication_url":"https://clinicaltrials.gov/study/NCT06786884","title":"A Pilot, Randomized Controlled Trial Evaluating the Effectiveness of Paraffin Wax On Burn Patient Function, Range of Motion and Scar","has_exemption":false,"start_date":"2025-01-06","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792110","publication_url":"https://clinicaltrials.gov/study/NCT06792110","title":"Evaluation of Artificial Intelligence-Integrated Hearing Aids for Individuals with Hearing Loss","has_exemption":false,"start_date":"2025-02-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06839482","publication_url":"https://clinicaltrials.gov/study/NCT06839482","title":"Efficacy of Robotic Rehabilitation for Neuro Recovery of the Upper Limb in Subacute Stroke Survivors: An International Multicenter Randomized Controlled Trial","has_exemption":false,"start_date":"2025-02-06","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"IRCCS San Raffaele Roma","sponsor_slug":"irccs-san-raffaele-roma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06813430","publication_url":"https://clinicaltrials.gov/study/NCT06813430","title":"Enhancing Healing With Non-Contact Low-Frequency Ultrasound in Fingertip Amputation Treatment: A Prospective Comparative Cohort Study","has_exemption":false,"start_date":"2025-02-10","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"St. Luke's Hospital, Pennsylvania","sponsor_slug":"st-lukes-hospital-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616844","publication_url":"https://clinicaltrials.gov/study/NCT06616844","title":"Evaluating the Efficacy of Porcine Placental Extracellular Matrix Augmented Wound Care Against Standard Wound Care for the Management of Diabetic Foot Ulcers: A Multi-center, Prospective, Observer-blinded, Randomized Controlled Clinical Trial.","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"ConvaTec Inc.","sponsor_slug":"convatec-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06759272","publication_url":"https://clinicaltrials.gov/study/NCT06759272","title":"Pharmacogenomic Markers of Clopidogrel Resistance in Malaysian CAD Patients: Clinical Efficacy and Economic Evaluation of CYP2C19 Genotype-Guided Therapy","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Nur Hafizah Annezah binti Utuh","sponsor_slug":"nur-hafizah-annezah-binti-utuh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06765824","publication_url":"https://clinicaltrials.gov/study/NCT06765824","title":"Transcranial Magnetic Stimulation in the Treatment of Dual Disorders: Study in Patients with Depression and Tobacco Addiction","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Cardenal Herrera University","sponsor_slug":"cardenal-herrera-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299891","publication_url":"https://clinicaltrials.gov/study/NCT06299891","title":"Phentermine/Topiramate in Children, Adolescents, and Young Adults With Hypothalamic Obesity: a Pilot and Feasibility Study","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Seattle Children's Hospital","sponsor_slug":"seattle-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06842771","publication_url":"https://clinicaltrials.gov/study/NCT06842771","title":"Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Tennessee","sponsor_slug":"university-of-tennessee","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06936670","publication_url":"https://clinicaltrials.gov/study/NCT06936670","title":"Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes","has_exemption":false,"start_date":"2025-04-30","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Seattle Children's Hospital","sponsor_slug":"seattle-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07046975","publication_url":"https://clinicaltrials.gov/study/NCT07046975","title":"Bioavailability and Bioequivalence (BA/BE) Study of Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Human Subjects","has_exemption":false,"start_date":"2025-06-15","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Sarfez Pharmaceuticals, Inc.","sponsor_slug":"sarfez-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07268586","publication_url":"https://clinicaltrials.gov/study/NCT07268586","title":"Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","has_exemption":false,"start_date":"2025-08-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Ain Shams University","sponsor_slug":"ain-shams-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220408","publication_url":"https://clinicaltrials.gov/study/NCT07220408","title":"A Single Center, Randomized, Double-masked, Vehicle Controlled Phase 2 Study Evaluating the Safety and Efficacy of TL-925 Ophthalmic Emulsion 0.1% Compared to Vehicle for the Treatment of Seasonal Allergic Conjunctivitis in the Conjunctival Allergen Challenge (Ora-CAC®) Model","has_exemption":false,"start_date":"2025-10-23","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Telios Pharma, Inc.","sponsor_slug":"telios-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161622","publication_url":"https://clinicaltrials.gov/study/NCT07161622","title":"Effects of Low Level Laser Therapy Versus Muscle Energy Techniques Among Diabetic Patients With Frozen Shoulder","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Lahore","sponsor_slug":"university-of-lahore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325162","publication_url":"https://clinicaltrials.gov/study/NCT07325162","title":"Development of a Next-Generation Optical Biometer for Eyes With Cataract","has_exemption":false,"start_date":"2025-11-07","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Cassini Technologies","sponsor_slug":"cassini-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321834","publication_url":"https://clinicaltrials.gov/study/NCT07321834","title":"A Phase 2, Randomized, Double-blind, Vehicle-Controlled, Multi-Center Clinical Trial Study to Evaluate Ready to Use Injectable AI-09 In Participants With Glabellar Lines","has_exemption":false,"start_date":"2025-12-03","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Eirion Therapeutics Inc.","sponsor_slug":"eirion-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096856","publication_url":"https://clinicaltrials.gov/study/NCT07096856","title":"Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System","has_exemption":false,"start_date":"2025-12-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"CMR Surgical Ltd","sponsor_slug":"cmr-surgical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07311733","publication_url":"https://clinicaltrials.gov/study/NCT07311733","title":"Milky Way Sensor: Device Validation for Infiltrated Tissues","has_exemption":false,"start_date":"2026-01-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"ivWatch, LLC","sponsor_slug":"ivwatch-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03428828","publication_url":"https://clinicaltrials.gov/study/NCT03428828","title":"Amygdala rtfMRI Neurofeedback for Treatment Resistant Depression","has_exemption":false,"start_date":"2018-10-22","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Kymberly Young","sponsor_slug":"kymberly-young","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03284385","publication_url":"https://clinicaltrials.gov/study/NCT03284385","title":"A Phase 2 Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies","has_exemption":false,"start_date":"2019-01-29","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04069312","publication_url":"https://clinicaltrials.gov/study/NCT04069312","title":"Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)","has_exemption":false,"start_date":"2020-02-11","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04111172","publication_url":"https://clinicaltrials.gov/study/NCT04111172","title":"A Phase 2A, Dose-Finding Study of Ad5.F35-hGCC-PADRE Vaccine in Adults With Gastrointestinal Adenocarcinomas at Risk of Relapse Post Definitive Surgery and Standard Therapy","has_exemption":false,"start_date":"2020-11-10","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04260256","publication_url":"https://clinicaltrials.gov/study/NCT04260256","title":"A Pilot Study of Using [18F]F AraG PET Imaging to Evaluate the Immunological Response to Checkpoint Inhibitor Therapy (CkIT) in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"CellSight Technologies, Inc.","sponsor_slug":"cellsight-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05207709","publication_url":"https://clinicaltrials.gov/study/NCT05207709","title":"A Phase III, Multicenter, Open-label Study of Ribociclib vs. Palbociclib in Patients With Advanced Hormone Receptor-positive/HER2-negative/HER2-Enriched Breast Cancer - HARMONIA Trial","has_exemption":false,"start_date":"2022-03-28","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"SOLTI Breast Cancer Research Group","sponsor_slug":"solti-breast-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05446467","publication_url":"https://clinicaltrials.gov/study/NCT05446467","title":"Safety and Efficacy of Pembrolizumab in Combination With Low-dose PF (Cisplatin and 5-Fluorouracil) as Neoadjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma: a Multi-center, Single-arm Clinical Study Trial","has_exemption":false,"start_date":"2022-09-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Zhejiang Provincial People's Hospital","sponsor_slug":"zhejiang-provincial-peoples-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05629494","publication_url":"https://clinicaltrials.gov/study/NCT05629494","title":"Effect of Non-steroidal Anti-inflammatory Drugs on Serum Prostate Specific Antigen Level","has_exemption":false,"start_date":"2022-09-27","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05306301","publication_url":"https://clinicaltrials.gov/study/NCT05306301","title":"Combination of Ponatinib Plus Chemotherapy As Frontline Treatment For Patients With BCR/ABL1-Like Acute Lymphoblastic Leukemia (BCR/ABL1-Like ALL)","has_exemption":false,"start_date":"2022-10-05","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Gruppo Italiano Malattie EMatologiche dell'Adulto","sponsor_slug":"gruppo-italiano-malattie-ematologiche-delladulto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06206265","publication_url":"https://clinicaltrials.gov/study/NCT06206265","title":"A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design","has_exemption":false,"start_date":"2024-01-17","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"TRYP Therapeutics","sponsor_slug":"tryp-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06278909","publication_url":"https://clinicaltrials.gov/study/NCT06278909","title":"Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study","has_exemption":false,"start_date":"2024-01-18","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Dr. Rafael Freire","sponsor_slug":"dr-rafael-freire","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06178588","publication_url":"https://clinicaltrials.gov/study/NCT06178588","title":"A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Previously Treated Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma","has_exemption":false,"start_date":"2024-02-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06258187","publication_url":"https://clinicaltrials.gov/study/NCT06258187","title":"Randomized Control Trial of Colorimetric CO2 Detectors for Ventilation Assessment in the Delivery Room","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06379425","publication_url":"https://clinicaltrials.gov/study/NCT06379425","title":"Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06250803","publication_url":"https://clinicaltrials.gov/study/NCT06250803","title":"Early Versus Late Pancreatic Stent Placement for Preventing Post-ERCP Pancreatitis: a Multicentre, Randomised Trial","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"The First Affiliated Hospital of Anhui Medical University","sponsor_slug":"the-first-affiliated-hospital-of-anhui-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06281678","publication_url":"https://clinicaltrials.gov/study/NCT06281678","title":"A Phase 2, Open-label, Multicenter Study of IBI363 (PD1-IL2m) in Subjects with Advanced Solid Malignancies","has_exemption":false,"start_date":"2024-04-08","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","sponsor_slug":"innovent-biologics-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07037264","publication_url":"https://clinicaltrials.gov/study/NCT07037264","title":"A Study of the Efficacy and Safety of Non-ablative Fractional Laser in the Treatment of Thyroidectomy Scars","has_exemption":false,"start_date":"2024-09-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Chinese Medical Association","sponsor_slug":"chinese-medical-association","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06426602","publication_url":"https://clinicaltrials.gov/study/NCT06426602","title":"Unlocking Functional Communication for Patients With Disorders of Consciousness With Innovative Brain Computer Interface Technology","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Amy Wagner","sponsor_slug":"amy-wagner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06845488","publication_url":"https://clinicaltrials.gov/study/NCT06845488","title":"Application of Virtual Reality Technology to Treatment of Social Anxiety","has_exemption":false,"start_date":"2024-11-07","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06853015","publication_url":"https://clinicaltrials.gov/study/NCT06853015","title":"Effects of Twice-daily Dosing 4-AP on Functional Recovery After Spinal Cord Injury","has_exemption":false,"start_date":"2025-02-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Shirley Ryan AbilityLab","sponsor_slug":"shirley-ryan-abilitylab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06761547","publication_url":"https://clinicaltrials.gov/study/NCT06761547","title":"Comparsion of Intravenous Injection of Magnesium Sulfate and Lidocaine Effectiveness on the Prevention of Laryngospasm and Analgesic Requirement in Tonsillectomy","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789575","publication_url":"https://clinicaltrials.gov/study/NCT06789575","title":"Comparison of Bupivacaine Wound Infiltration Versus Wound Instillation to Minimize Postoperative Pain After Thyroid Surgery","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789393","publication_url":"https://clinicaltrials.gov/study/NCT06789393","title":"Comparison of the Efficacy of Bupivacaine with and Without Dexmedetomidine As an Adjuvant on Penile Block for Postoperative Pain Relief in Pediatrics Undergoing Hypospadias Repair Surgery","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06820567","publication_url":"https://clinicaltrials.gov/study/NCT06820567","title":"English Title of Research Project: Effects of Dapagliflozin on Inflammatory Markers, Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861738","publication_url":"https://clinicaltrials.gov/study/NCT06861738","title":"Comaring the Effect of Paracetamol in Tratment of Headach","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06696118","publication_url":"https://clinicaltrials.gov/study/NCT06696118","title":"Electromagnetic Transduction Therapy (EMTT) on Mid-foot Osteoarthritis: A Pilot Study","has_exemption":false,"start_date":"2025-03-13","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06942182","publication_url":"https://clinicaltrials.gov/study/NCT06942182","title":"Double Blind Placebo-Controlled Parallel Group Study Of Safety And Efficacy Of Isomyosamine In Treating Sarcopenia After Hip Or Femoral Fracture In Gerontological Population","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"TNF Pharmaceuticals, Inc.","sponsor_slug":"tnf-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07093034","publication_url":"https://clinicaltrials.gov/study/NCT07093034","title":"Sustained Auricular Nerve Stimulation for PVC Suppression","has_exemption":false,"start_date":"2025-07-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06922942","publication_url":"https://clinicaltrials.gov/study/NCT06922942","title":"MS-FLOWER: MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Ad scientiam","sponsor_slug":"ad-scientiam","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184775","publication_url":"https://clinicaltrials.gov/study/NCT07184775","title":"Maternal Continuous Glucose Monitoring Surveillance Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07257133","publication_url":"https://clinicaltrials.gov/study/NCT07257133","title":"Opioid Avoidance In Surgery Through Integrating Suzetrigine: Post-Operative Care Phase Pilot","has_exemption":false,"start_date":"2025-10-20","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135947","publication_url":"https://clinicaltrials.gov/study/NCT07135947","title":"To Evaluate the Clinical Impact of the Point Powered System","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Point Designs","sponsor_slug":"point-designs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224295","publication_url":"https://clinicaltrials.gov/study/NCT07224295","title":"The Effect of Non Invasive Stellate Ganglion Disrupting on Sleep Disturbances on Postmenopausal Female","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07182058","publication_url":"https://clinicaltrials.gov/study/NCT07182058","title":"Virtual Remote Assessment of Transcranial Electrical Stimulation for Parkinson's Disease Motor Symptoms","has_exemption":false,"start_date":"2026-01-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"U: The Mind Company","sponsor_slug":"u-the-mind-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07331961","publication_url":"https://clinicaltrials.gov/study/NCT07331961","title":"Assessment of the Feasibility and Clinical Efficacy of Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT) Using the Dornier System in Patients With Vasculogenic Erectile Dysfunction: A Pilot Study","has_exemption":false,"start_date":"2026-01-01","completion_date":"2026-03-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02177292","publication_url":"https://clinicaltrials.gov/study/NCT02177292","title":"A Phase II Trial of High-Dose Pelvic Lymph Node IMRT( Intensity Modulated Radiation Therapy) and Hypofractionated Prostate IMRT for High Risk Prostate Cancer Patients","has_exemption":false,"start_date":"2010-06-23","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03226808","publication_url":"https://clinicaltrials.gov/study/NCT03226808","title":"Post Market Clinical Follow-up Study of the Zimmer Vivacit-E Highly Crosslinked Polyethylene Liner Used With the Continuum Acetabular Shell","has_exemption":false,"start_date":"2013-10-01","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03486821","publication_url":"https://clinicaltrials.gov/study/NCT03486821","title":"Pilot Trial of Ultra-hypofractionated Radiation in Early Prostate Cancer","has_exemption":false,"start_date":"2018-03-22","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03724175","publication_url":"https://clinicaltrials.gov/study/NCT03724175","title":"The Role of Secondary Bile Acids in Intestinal Inflammation","has_exemption":false,"start_date":"2019-08-26","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04450628","publication_url":"https://clinicaltrials.gov/study/NCT04450628","title":"Esophagogastric Junction Distensibility During Hiatal Hernia Repair","has_exemption":false,"start_date":"2020-09-28","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04404881","publication_url":"https://clinicaltrials.gov/study/NCT04404881","title":"A Phase 2 Study of Bevacizumab for Chronic Bleeding and Iron Deficiency Anemia in Hereditary Hemorrhagic Telangiectasia (Trial Using Systemic Bevacizumab to Treat HHT, TrUST-HHT)","has_exemption":false,"start_date":"2020-11-23","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Hanny Al-Samkari, MD","sponsor_slug":"hanny-al-samkari-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04300920","publication_url":"https://clinicaltrials.gov/study/NCT04300920","title":"Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial","has_exemption":false,"start_date":"2020-12-17","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Fernando J Martinez","sponsor_slug":"fernando-j-martinez","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04497168","publication_url":"https://clinicaltrials.gov/study/NCT04497168","title":"Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04620759","publication_url":"https://clinicaltrials.gov/study/NCT04620759","title":"Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder","has_exemption":false,"start_date":"2021-04-14","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04960709","publication_url":"https://clinicaltrials.gov/study/NCT04960709","title":"A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer (VOLGA)","has_exemption":false,"start_date":"2021-08-05","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04910776","publication_url":"https://clinicaltrials.gov/study/NCT04910776","title":"An Open-label, Multinational, Multicenter, Intravenous Infusion Study of the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Avalglucosidase Alfa in Treatment naïve Pediatric Participants With Infantile-Onset Pompe Disease (IOPD)","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05065424","publication_url":"https://clinicaltrials.gov/study/NCT05065424","title":"Use of Premedication for Less Invasive Surfactant Administration: A Randomized Control Trial","has_exemption":false,"start_date":"2022-04-06","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05074940","publication_url":"https://clinicaltrials.gov/study/NCT05074940","title":"Phase II Study to Evaluate Amivantamab in Recurrent and Metastatic Adenoid Cystic Carcinoma","has_exemption":false,"start_date":"2022-08-05","completion_date":"2026-03-02","has_results":true,"results_due":false,"sponsor_name":"Trisha Wise-Draper","sponsor_slug":"trisha-wise-draper","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05597891","publication_url":"https://clinicaltrials.gov/study/NCT05597891","title":"A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism (ENGULF)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Endovascular Engineering","sponsor_slug":"endovascular-engineering","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05751278","publication_url":"https://clinicaltrials.gov/study/NCT05751278","title":"A Randomized Trial of Cryoprobe Versus Forceps for Transbronchial Biopsy","has_exemption":false,"start_date":"2023-02-27","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05805436","publication_url":"https://clinicaltrials.gov/study/NCT05805436","title":"The Use of Preoperative Osmotic Laxatives to Improve Recovery of Bowel Function After Robotic-assisted Urologic Surgery","has_exemption":false,"start_date":"2023-06-01","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"Chad R. Tracy","sponsor_slug":"chad-r-tracy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06198959","publication_url":"https://clinicaltrials.gov/study/NCT06198959","title":"Heat Loss in Humans Covered With Full-Body Blankets Connected to Different Warming Devices","has_exemption":false,"start_date":"2024-02-15","completion_date":"2026-03-02","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06380179","publication_url":"https://clinicaltrials.gov/study/NCT06380179","title":"Assessing the Impact of Post-Exercise Photobiomodulation Application on Performance, Recovery, and Behavioral State in Trained Special Operator Population","has_exemption":false,"start_date":"2025-01-23","completion_date":"2026-03-02","has_results":true,"results_due":false,"sponsor_name":"Musculoskeletal Injury Rehabilitation Research for Operational Readiness","sponsor_slug":"musculoskeletal-injury-rehabilitation-research-for-operational-readiness","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02723994","publication_url":"https://clinicaltrials.gov/study/NCT02723994","title":"A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2016-09-30","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03561584","publication_url":"https://clinicaltrials.gov/study/NCT03561584","title":"A Randomized, Placebo-controlled Pilot Study of Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis (PSC)","has_exemption":false,"start_date":"2018-07-01","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06161571","publication_url":"https://clinicaltrials.gov/study/NCT06161571","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","has_exemption":false,"start_date":"2023-11-10","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Akero Therapeutics, Inc","sponsor_slug":"akero-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05959018","publication_url":"https://clinicaltrials.gov/study/NCT05959018","title":"Efficacy & Health Economics of Antimicrobial-impregnated Central Venous Catheters (CVCs) Compared to Non-impregnated CVCs in Central Line-associated Bloodstream Infection Prevention in a Malaysia University Hospital Adult ICU","has_exemption":false,"start_date":"2024-01-19","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"University of Malaya","sponsor_slug":"university-of-malaya","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054659","publication_url":"https://clinicaltrials.gov/study/NCT06054659","title":"A Randomized Controlled Open-label Study Comparing the Use of Real-time Continuous Glucose Monitoring (Rt-CGM) to Point of Care Testing (POCT) for Glycemic Monitoring in Patients Post-hospitalization for Diabetic Foot Ulcers.","has_exemption":false,"start_date":"2024-02-20","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06502366","publication_url":"https://clinicaltrials.gov/study/NCT06502366","title":"A Randomized, Placebo-controlled, Double-blind, Multicenter, 12-Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared With BDA Delivered by MDI HFA in Participants With Asthma","has_exemption":false,"start_date":"2024-07-22","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06602453","publication_url":"https://clinicaltrials.gov/study/NCT06602453","title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury and Major Adverse Kidney Events","has_exemption":false,"start_date":"2025-01-17","completion_date":"2026-03-03","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03438708","publication_url":"https://clinicaltrials.gov/study/NCT03438708","title":"\"PADRES\" (Prior Axitinib as a Determinant of Outcome of REnal Surgery)","has_exemption":false,"start_date":"2018-03-05","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03519945","publication_url":"https://clinicaltrials.gov/study/NCT03519945","title":"A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3","has_exemption":false,"start_date":"2018-07-18","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05152914","publication_url":"https://clinicaltrials.gov/study/NCT05152914","title":"Intravitreal Enzyme Replacement Therapy to Prevent Retinal Disease Progression in Children With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2)","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"David L Rogers, MD","sponsor_slug":"david-l-rogers-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05348577","publication_url":"https://clinicaltrials.gov/study/NCT05348577","title":"A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2022-03-25","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06128564","publication_url":"https://clinicaltrials.gov/study/NCT06128564","title":"A Two-Part, Open-Label Systemic Gene Delivery Study to Evaluate the Safety and Expression of RO7494222 (SRP-9001) in Subjects Under the Age of Four With Duchenne Muscular Dystrophy","has_exemption":false,"start_date":"2023-11-29","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06221969","publication_url":"https://clinicaltrials.gov/study/NCT06221969","title":"Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) 2.4 mg/2.4 mg s.c. Once Weekly Versus Tirzepatide 15 mg s.c. Once Weekly in Participants With Type 2 Diabetes Inadequately Controlled on Metformin With or Without an SGLT2 Inhibitor","has_exemption":false,"start_date":"2024-01-16","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06290934","publication_url":"https://clinicaltrials.gov/study/NCT06290934","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)","has_exemption":false,"start_date":"2024-03-27","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625398","publication_url":"https://clinicaltrials.gov/study/NCT06625398","title":"REVEAL-2 - A Phase 3, Randomized, Double-masked, Placebo-controlled, Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)","has_exemption":false,"start_date":"2024-08-27","completion_date":"2026-03-04","has_results":false,"results_due":false,"sponsor_name":"Viridian Therapeutics, Inc.","sponsor_slug":"viridian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03404193","publication_url":"https://clinicaltrials.gov/study/NCT03404193","title":"A Phase II Study of Venetoclax in Combination With 10-Day Decitabine in Newly Diagnosed Elderly or Relapsed/Refractory Acute Myeloid Leukemia and Relapsed High-Risk Myelodysplastic Syndrome and Blastic Plasmacytoid Dendritic Cell Neoplasm","has_exemption":false,"start_date":"2018-01-18","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04629495","publication_url":"https://clinicaltrials.gov/study/NCT04629495","title":"Rapamycin - Effects on Alzheimer's and Cognitive Health (REACH)","has_exemption":false,"start_date":"2021-08-11","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06109441","publication_url":"https://clinicaltrials.gov/study/NCT06109441","title":"Phase 2a, Multicenter, Open-Label Study Evaluating the Efficacy and Safety of ALTB-268 in Subjects With Moderately to Severely Active Ulcerative Colitis Refractory to Biologic Therapy","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"AltruBio Inc.","sponsor_slug":"altrubio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06295809","publication_url":"https://clinicaltrials.gov/study/NCT06295809","title":"A Phase 2/3, Adaptive, Randomized, Open-label, Clinical Study to Evaluate Neoadjuvant and Adjuvant Intismeran Autogene (mRNA-4157) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care, and Pembrolizumab Monotherapy in Participants With Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (INTerpath-007)","has_exemption":false,"start_date":"2024-04-18","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06608238","publication_url":"https://clinicaltrials.gov/study/NCT06608238","title":"A Randomized, Double-blind, Three-arm Phase 2 Study Evaluating Two Dose Levels of Microneedle-mediated Delivery of Doxorubicin Compared With a Device-only Control in Patients With Nodular Basal Cell Carcinoma.","has_exemption":false,"start_date":"2024-09-03","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"SkinJect, Inc.","sponsor_slug":"skinject-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07317648","publication_url":"https://clinicaltrials.gov/study/NCT07317648","title":"ClearSight NextGen System Clinical Development Study","has_exemption":false,"start_date":"2025-10-16","completion_date":"2026-03-05","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03680508","publication_url":"https://clinicaltrials.gov/study/NCT03680508","title":"Phase II Study of TSR-022 (Cobolimab) in Combination With TSR-042 (Dostarlimab) for the Treatment of Advanced Hepatocellular Carcinoma","has_exemption":false,"start_date":"2019-12-19","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"University of Hawaii","sponsor_slug":"university-of-hawaii","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04574167","publication_url":"https://clinicaltrials.gov/study/NCT04574167","title":"Effects of tDCS Paired With Cognitive Training on Brain Networks Associated With Alcohol Use Disorder in Veterans","has_exemption":false,"start_date":"2020-01-01","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05023655","publication_url":"https://clinicaltrials.gov/study/NCT05023655","title":"A Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation","has_exemption":false,"start_date":"2022-01-06","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"Prisma Health-Upstate","sponsor_slug":"prisma-health-upstate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06040086","publication_url":"https://clinicaltrials.gov/study/NCT06040086","title":"A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab in Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations (MIRANDA)","has_exemption":false,"start_date":"2023-09-22","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05963997","publication_url":"https://clinicaltrials.gov/study/NCT05963997","title":"A Phase 1b/2 Open-label Study of Samuraciclib in Combination With Elacestrant in Participants With Metastatic or Locally Advanced Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-negative Breast Cancer","has_exemption":false,"start_date":"2023-10-09","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"Carrick Therapeutics Limited","sponsor_slug":"carrick-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05736406","publication_url":"https://clinicaltrials.gov/study/NCT05736406","title":"An Interventional, Multicenter, and International Phase 1/2, Light-dose-escalation Study to Investigate the Safety and Feasibility of Intraoperative Photodynamic Therapy (PDT) With Pentalafen® Drug and Heliance® Solution Device in Male and Female Patients 18 to 75 Years of Age With Grade IV Glioblastoma.","has_exemption":false,"start_date":"2024-02-20","completion_date":"2026-03-06","has_results":false,"results_due":false,"sponsor_name":"Hemerion Therapeutics","sponsor_slug":"hemerion-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04100564","publication_url":"https://clinicaltrials.gov/study/NCT04100564","title":"Prehospital Airway Control Trial : A Randomized Controlled Trial of Prehospital Airway Management Strategy for Trauma Patients","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-03-07","has_results":false,"results_due":false,"sponsor_name":"Jason Sperry","sponsor_slug":"jason-sperry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05066113","publication_url":"https://clinicaltrials.gov/study/NCT05066113","title":"Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin","has_exemption":false,"start_date":"2017-08-15","completion_date":"2026-03-08","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05611242","publication_url":"https://clinicaltrials.gov/study/NCT05611242","title":"Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial","has_exemption":false,"start_date":"2024-05-08","completion_date":"2026-03-08","has_results":false,"results_due":false,"sponsor_name":"Mercy Health, Ohio","sponsor_slug":"mercy-health-ohio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04178018","publication_url":"https://clinicaltrials.gov/study/NCT04178018","title":"Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary","has_exemption":false,"start_date":"2020-02-09","completion_date":"2026-03-09","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03904498","publication_url":"https://clinicaltrials.gov/study/NCT03904498","title":"COMT Inhibition as a Potential Therapeutic Target Among Individuals With Comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder","has_exemption":false,"start_date":"2021-08-16","completion_date":"2026-03-09","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05348785","publication_url":"https://clinicaltrials.gov/study/NCT05348785","title":"A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease","has_exemption":false,"start_date":"2022-04-19","completion_date":"2026-03-09","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05725902","publication_url":"https://clinicaltrials.gov/study/NCT05725902","title":"A Pilot Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease","has_exemption":false,"start_date":"2024-03-09","completion_date":"2026-03-09","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919172","publication_url":"https://clinicaltrials.gov/study/NCT06919172","title":"iTBS/fMRI Study of Apex Control","has_exemption":false,"start_date":"2025-01-06","completion_date":"2026-03-09","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03937154","publication_url":"https://clinicaltrials.gov/study/NCT03937154","title":"PROCLAIM: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer","has_exemption":false,"start_date":"2020-02-26","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05440643","publication_url":"https://clinicaltrials.gov/study/NCT05440643","title":"A Phase I/II Trial in 3 Parts Assessing the Safety, Tolerability, and Efficacy of a Once-daily Peanut Sublingual Immunotherapy (SLIT) Tablet in Adults, Adolescents, and Children With Peanut Allergy","has_exemption":false,"start_date":"2022-09-07","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"ALK-Abelló A/S","sponsor_slug":"alk-abello-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05081245","publication_url":"https://clinicaltrials.gov/study/NCT05081245","title":"A Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD).","has_exemption":false,"start_date":"2022-09-13","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"MapLight Therapeutics","sponsor_slug":"maplight-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05109364","publication_url":"https://clinicaltrials.gov/study/NCT05109364","title":"The Effect of alpha1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up Study","has_exemption":false,"start_date":"2022-09-23","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06130501","publication_url":"https://clinicaltrials.gov/study/NCT06130501","title":"IMBUE RETAIN: Transcutaneous Auricular Neurostimulation (tAN) for Patients With Co-occurring Posttraumatic Stress Disorder (PTSD) and Opioid Use Disorder Starting Buprenorphine Therapy","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07103720","publication_url":"https://clinicaltrials.gov/study/NCT07103720","title":"The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron","has_exemption":false,"start_date":"2025-11-05","completion_date":"2026-03-10","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04225156","publication_url":"https://clinicaltrials.gov/study/NCT04225156","title":"A Phase 3, Multicenter, Open-label, Long-term Trial to Evaluate the Safety and Efficacy of Efgartigimod (ARGX 113) 10 mg/kg Intravenous in Adult Patients With Primary Immune Thrombocytopenia.","has_exemption":false,"start_date":"2020-06-02","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04904302","publication_url":"https://clinicaltrials.gov/study/NCT04904302","title":"A Phase II Trial of Sitravatinib Plus Nivolumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma Who Progressed on Prior Treatment Acronym: SNAPI (Sitravatinib and Nivolumab After Prior Immunotherapy)","has_exemption":false,"start_date":"2022-05-03","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05399888","publication_url":"https://clinicaltrials.gov/study/NCT05399888","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease Dementia","has_exemption":false,"start_date":"2022-08-24","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492304","publication_url":"https://clinicaltrials.gov/study/NCT06492304","title":"A Phase 1/2 Dose Evaluation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed/Refractory Hematologic Malignancies","has_exemption":false,"start_date":"2024-08-13","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"CRISPR Therapeutics","sponsor_slug":"crispr-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06815965","publication_url":"https://clinicaltrials.gov/study/NCT06815965","title":"An Open-Label Phase 2a Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Dementia With Lewy Bodies (DLB)","has_exemption":false,"start_date":"2024-10-16","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"EIP Pharma Inc","sponsor_slug":"eip-pharma-inc","status":"ongoing","is_pact":false,"days_late":null}]}